ADVFN Logo

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for charts Cadastre-se para gráficos em tempo real, ferramentas de análise e preços.

OKYO Okyo Pharma Limited

91,00
0,00 (0,00%)
27 Mar 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Okyo Pharma Limited OKYO Londres Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
0,00 0,00% 91,00 21:00:00
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
91,00 91,00
mais cotações »
Setor da Empresa
MINING

Notícias Recentes

Data Hora Fonte Título
09/02/202409:36IHNWOKYO Pharma Receives FDA Approval of IND for OK-101 in..
08/01/202409:00GLOBEOKYO Pharma Announces OK-101 Successfully Achieved..
05/01/202411:30GLOBEOKYO Pharma to Present at the Biotech Showcase Conference in..
04/12/202309:00GLOBEOKYO Pharma Announces Last Patient Enrolled in OK-101 Phase..
31/10/202308:00GLOBEOKYO Pharma Announces $5.84 Million Cash Raise and Payables..
09/10/202308:00GLOBEOKYO Pharma Announces Filing of an Investigational New Drug..
05/10/202308:00GLOBEOKYO Pharma Announces Positive Safety Data Profile for the..
15/09/202308:00GLOBEOKYO Pharma Announces Closing of $4.0 Million Registered..
14/09/202310:15GLOBEOKYO Pharma Announces Pricing of $4.0 Million Registered..
14/09/202309:45GLOBEOKYO Pharma Limited Announces Withdrawal of Public Offering
13/09/202317:05GLOBEOKYO Pharma Announces Public Offering of Ordinary Shares
08/09/202308:00GLOBEOKYO Pharma Completes Enrollment in Phase 2 Clinical Trial..
30/08/202308:00GLOBEOKYO Pharma Achieves 90% Enrollment in 240-Patient Phase 2..
29/08/202308:00GLOBEOKYO Pharma Limited Regains Compliance with Nasdaq Listing..
15/08/202310:00GLOBEOKYO Pharma Limited Reports Annual Results for the Twelve..
31/07/202303:18GLOBEOKYO Pharma Limited Announces Withdrawal of Public Offering
28/07/202318:25GLOBEOKYO Pharma Announces Proposed Public Offering of Ordinary..
28/07/202318:05GLOBEOKYO Pharma Limited Receives Nasdaq Deficiency Notice
28/07/202308:01GLOBEOKYO Pharma Plans to Initiate Phase 2 Trial of OK-101 in..
27/07/202312:30GLOBEOKYO Pharma Announces Appointment of William A. Clementi as..
06/06/202310:30GLOBEOKYO Pharma Announces Randomized Segment Now Underway in..
19/05/202307:22ALNCNewsIN BRIEF: Okyo Pharma to move shares to New York with London..
19/05/202304:00RNSNONOKYO Pharma Limited ADS Program collapse
11/05/202310:27ALNCNewsIN BRIEF: Okyo Pharma delays delisting from London trading..
11/05/202308:00RNSNONOKYO Pharma Limited Webull Corporate Communications Service..
03/05/202303:00RNSNONOKYO Pharma Limited Presentation on OK-101 at ASCRS
02/05/202316:16ALNCNewsTRADING UPDATES: Knights Group buys St James Law and Baines..
02/05/202303:00GLOBEOKYO Pharma Announces First-Patient First-Visit for Phase 2..
25/04/202312:19ALNCNewsTRADING UPDATES: Eckoh expects profit up; LXi REIT..
25/04/202303:00GLOBEOKYO Pharma Announces Activation of First Clinical Trial..
05/04/202303:00GLOBENotice of General Meeting and Publication of Circular
04/04/202305:08ALNCNewsOkyo Pharma applies to delist from London Stock Exchange due..
04/04/202303:00GLOBENotice of Intention to Delist From The London Stock Exchange
30/03/202303:01GLOBEOKYO Pharma Today Announces Director Acquires Shares
29/03/202303:00GLOBEOKYO Pharma Today Announces Director Acquires Shares

Seu Histórico Recente

Delayed Upgrade Clock